Invasion of primary glioma- and cell line-derived spheroids implanted into corticostriatal slice cultures

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 4, 2013, Pages 546-560

  Aaberg Jessen, Charlotte ^a,b   Nørregaard, Annette ^a,b   Christensen, Karina ^a   Pedersen, Christian B ^a   Andersen, Claus ^a,b   Kristensen, Bjarne W ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Glioma; Invasion; Organotypic slice cultures; Spheroids

Indexed keywords

CD133 ANTIGEN; GLYCOPROTEIN; INTERMEDIATE FILAMENT PROTEIN; LEUKOCYTE ANTIGEN; NERVE PROTEIN; NESTIN; ONCOPROTEIN; PEPTIDE; TRANSCRIPTION FACTOR SOX;

ANIMAL; ARTICLE; ASTROCYTOMA; BRAIN; BRAIN TUMOR; CELL MOTION; COCULTURE; CONFOCAL MICROSCOPY; DISEASE MODEL; GLIOMA; HUMAN; IN VITRO STUDY; INVASION; METABOLISM; MULTICELLULAR SPHEROID; ORGANOTYPIC SLICE CULTURES; PATHOLOGY; PHYSIOLOGY; RAT; TISSUE CULTURE TECHNIQUE; TUMOR SPHEROID; WISTAR RAT;

GLIOMA; INVASION; ORGANOTYPIC SLICE CULTURES; SPHEROIDS;

ANIMALS; ANTIGENS, CD; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; CELL MOVEMENT; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; GLIOMA; GLYCOPROTEINS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MICROSCOPY, CONFOCAL; NERVE TISSUE PROTEINS; PEPTIDES; PROTO-ONCOGENE PROTEINS; RATS; RATS, WISTAR; SOXB1 TRANSCRIPTION FACTORS; SPHEROIDS, CELLULAR; TISSUE CULTURE TECHNIQUES;

EID: 84883022783     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiation Oncology G and National Cancer Institute of Canada Clinical Trials G. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 459-466.
2. Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SA, Fack F, Thorsen F, Taxt T, Bartos M, Jirik R, Miletic H, Wang J, Stieber D, Stuhr L, Moen I, Rygh CB, Bjerkvig R and Niclou SP. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci U S A 2011; 108: 3749-3754.
3. Bjerkvig R, Tonnesen A, Laerum OD and Backlund EO. Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg 1990; 72: 463-475.
4. De Witt Hamer PC, Jonker A, Leenstra S, Ruijter JM, and Van Noorden CJ. Quantification of viability in organotypic multicellular spheroids of human malignant glioma using lactate dehydrogenase activity: a rapid, and reliable automated assay. J Histochem Cytochem 2005; 53: 23-34.
5. Kaaijk P, Troost D, Das PK, Leenstra S, and Bosch DA. Long-term culture of organotypic multicellular glioma spheroids: a good culture model for studying gliomas. Neuropathol Appl Neurobiol 1995; 21: 386-391.
6. Kaaijk P, Troost D, Sminia P, Hulshof MC, van der Kracht AH, Leenstra S, and Bosch DA. Hypofractionated radiation induces a decrease in cell proliferation but no histological damage to organotypic multicellular spheroids of humanglioblastomas. Eur J Cancer 1997; 33: 645-651.
7. Sminia P, Acker H, Eikesdal HP, Kaaijk P, Enger P, Slotman B, and Bjerkvig R. Oxygenation, and response to irradiation of organotypic multicellular spheroids of human glioma. Anticancer Res 2003; 23: 1461-1466.
8. Fehlauer F, Muench M, Rades D, Stalpers LJ, Leenstra S, van der Valk P, Slotman B, Smid EJ, and Sminia P. Effects of irradiation, and cisplatin on human glioma spheroids: inhibition of cell proliferation, and cell migration. J Cancer Res Clin Oncol 2005; 131: 723-732.
9. Fehlauer F, Muench M, Smid EJ, Slotman B, Richter E, Van der Valk P, and Sminia P. Combined modality therapy of gemcitabine, and irradiation on human glioma spheroids derived from cell lines, and biopsy tissue. Oncol Rep 2006; 15: 97-105.
10. Fehlauer F, Stalpers LJ, Panayiotides J, Kaaijk P, Gonzalez Gonzalez D, Leenstra S, van der Valk P, and Sminia P. Effect of single dose irradiation on human glioblastoma spheroids in vitro. Oncol Rep 2004; 11: 477-485.
11. Lund-Johansen M, Engebraaten O, Bjerkvig R, and Laerum OD. Invasive glioma cells in tissue culture. Anticancer Res 1990; 10: 1135-1151.
12. Ponten J, and Macintyre EH. Long term culture of normal, and neoplastic human glia. Acta Pathol Microbiol Scand 1968; 74: 465-486.
13. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumors of the Central Nervous System. International Agency for Research on Cancer (IARC), 2007.
14. Engebraaten O, Hjortland GO, Hirschberg H, and Fodstad O. Growth of precultured human glioma specimens in nude rat brain. J Neurosurg 1999; 90: 125-132.
15. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F, and Vescovi A. Isolation, and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64: 7011-7021.
16. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, and Fine HA. Tumor stem cells derived from glioblastomas cultured in bFGF, and EGF more closely mirror the phenotype, and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9: 391-403.
17. Yu SC, Ping YF, Yi L, Zhou ZH, Chen JH, Yao XH, Gao L, Wang JM, and Bian XW. Isolation, and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett 2008; 265: 124-134.
18. Ironside JW and Moss TH. Astrocytic tumors. 2002.
19. Palfi S, Swanson KR, De Bouard S, Chretien F, Oliveira R, Gherardi RK, Kros JM, Peschanski M, and Christov C. Correlation of in vitro infiltration with glioma histological type in organotypic brain slices. Br J Cancer 2004; 91: 745-752.
20. Matsumura H, Ohnishi T, Kanemura Y, Maruno M, and Yoshimine T. Quantitative analysis of glioma cell invasion by confocal laser scanning microscopy in a novel brain slice model. Biochem Biophys Res Commun 2000; 269: 513-520.
21. de Bouard S, Christov C, Guillamo JS, Kassar-Duchossoy L, Palfi S, Leguerinel C, Masset M, Cohen-Hagenauer O, Peschanski M, and Lefrancois T. Invasion of human glioma biopsy specimens in cultures of rodent brain slices: a quantitative analysis. J Neurosurg 2002; 97: 169-176.
22. Jung S, Kim HW, Lee JH, Kang SS, Rhu HH, Jeong YI, Yang SY, Chung HY, Bae CS, Choi C, Shin BA, Kim KK, and Ahn KY. Brain tumor invasion model system using organotypic brain-slice culture as an alternative to in vivo model. J Cancer Res Clin Oncol 2002; 128: 469-476.
23. Khoshyomn S, Penar PL, McBride WJ, and Taatjes DJ. Four-dimensional analysis of human brain tumor spheroid invasion into fetal rat brain aggregates using confocal scanning laser microscopy. J Neurooncol 1998; 38: 1-10.
24. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, and Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756-760.
25. Chargari C, Moncharmont C, Levy A, Guy JB, Bertrand G, Guilbert M, Rousseau C, Vedrine L, Alphonse G, Toillon RA, Rodriguez-Lafrasse C, Deutsch E, and Magne N. Cancer stem cells, cornerstone of radioresistance, and perspectives for radiosensitization: glioblastoma as an example. Bull Cancer 2012; 99: 1153-60.
26. Hambardzumyan D, Squatrito M, and Holland EC. Radiation resistance, and stem-like cells in brain tumors. Cancer Cell 2006; 10: 454-456.
27. Kang MK, and Kang SK. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev 2007; 16: 837-847.
28. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, and Yu JS. Analysis of gene expression, and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006; 5: 67.
29. Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T, Hamou MF, de Tribolet N, Regli L, Wick W, Kouwenhoven MC, Hainfellner JA, Heppner FL, Dietrich PY, Zimmer Y, Cairncross JG, Janzer RC, Domany E, Delorenzi M, Stupp R, andHegi ME. Stem cell-related "self-renewal" signature, and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 2008; 26: 3015-3024.
30. Singh SK, Clarke ID, Hide T, and Dirks PB. Cancer stem cells in nervous system tumors. Oncogene 2004; 23: 7267-7273.
31. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, and Dirks PB. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
32. Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B, and Herold-Mende CC. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 2008; 14: 123-129.
33. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, and Kornblum HI. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 2003; 100: 15178-15183.
34. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD, and Rich JN. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006; 66: 7843-7848.
35. Kang MK, Hur BI, Ko MH, Kim CH, Cha SH, and Kang SK. Potential identity of multi-potential cancer stem-like subpopulation after radiation of cultured brain glioma. BMC Neurosci 2008; 9: 15.
36. Christensen K, Schrøder HD, and Kristensen BW. CD133+ niches, and single cells in glioblastoma have different phenotypes. J Neurooncol 2011; 104: 129-143.
37. Christensen K, Schrøder HD, and Kristensen BW. CD133 identifies perivascular niches in grade II-IV astrocytomas. J Neurooncol 2008; 90: 157-170.
38. Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, and Frisen J. Identification of a neural stem cell in the adult mammalian central nervous system. Cell 1999; 96: 25-34.
39. Strojnik T, Rosland GV, Sakariassen PO, Kavalar R, and Lah T. Neural stem cell markers, nestin, and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol 2007; 68: 133-143; discussion 143-134.
40. Maderna E, Salmaggi A, Calatozzolo C, Limido L, and Pollo B. Nestin, PDGFRbeta, CXCL12, and VEGF in glioma patients: different profiles of (pro-angiogenic) molecule expression are related with tumor grade, and may provide prog[nostic information. Cancer Biol Ther 2007; 6: 1018-1024.
41. Schmitz M, Temme A, Senner V, Ebner R, Schwind S, Stevanovic S, Wehner R, Schackert G, Schackert HK, Fussel M, Bachmann M, Rieber EP, and Weigle B. Identification of SOX2 as a novel glioma-associated antigen, and potential target for T cell-based immunotherapy. Br J Cancer 2007; 96: 1293-1301.
42. Vonlanthen S, Heighway J, Altermatt HJ, Gugger M, Kappeler A, Borner MM, van Lohuizen M, and Betticher DC. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer, and correlates with INK4A-ARF locus expression. Br J Cancer 2001; 84: 1372-1376.
43. Glinsky GV, Berezovska O, and Glinskii AB. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 2005; 115: 1503-1521.
44. Kristensen BW, Noraberg J, Jakobsen B, Gramsbergen JB, Ebert B, and Zimmer J. Excitotoxic effects of non-NMDA receptor agonists in organotypic corticostriatal slice cultures. Brain Res 1999; 841: 143-159.
45. Stoppini L, Buchs PA, and Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 1991; 37: 173-182.
46. Jung S, Ackerley C, Ivanchuk S, Mondal S, Becker LE, and Rutka JT. Tracking the invasiveness of human astrocytoma cells by using green fluorescent protein in an organotypical brain slice model. J Neurosurg 2001; 94: 80-89
47. Giese A, Loo MA, Tran N, Haskett D, Coons SW, and Berens ME Dichotomy of astrocytoma migration, and proliferation. Int J Cancer 1996; 67: 275-282.
48. Christensen K, Aaberg-Jessen C,, Andersen C, Goplen D, Bjerkvig R, and Kristensen BW. Immunohistochemical expression of stem cell, endothelial cell,, and chemosensitivity markers in primary glioma spheroids cultured in serum-containing, and serum-free medium. Neurosurgery 2010; 66: 933-947.
49. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, and Dirks PB. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-5828.
50. Noraberg J, Kristensen BW, and Zimmer J. Markers for neuronal degeneration in organotypic slice cultures. Brain Res Brain Res Protoc 1999; 3: 278-290.
51. Benardete EA, and Bergold PJ. Genomic analysis of ischemic preconditioning in adult rat hippocampal slice cultures. Brain Res 2009; 1292: 107-122.
52. Hassen GW, Tian D, Ding D, and Bergold PJ. A new model of ischemic preconditioning using young adult hippocampal slice cultures. Brain Res Brain Res Protoc 2004; 13: 135-143.